U.S. News: City of Hope Is Best Cancer Hospital in the West

July 29, 2019 | Letisia Marquez

City of Hope has been named the best cancer hospital in the West by U.S. News & World Report’s 2019-20 Best Hospitals: Specialty Ranking. This marks the 13th consecutive year it has been distinguished as one of the nation’s elite cancer hospitals.

Continue Reading

Anti-PD-L1 checkpoint inhibitors: Decoding the mystery

July 24, 2019 | City of Hope

An study conducted by Michael Caligiuri, M.D., and Jianhua Yu, Ph.D., unveiled why anti-PD-L1 monoclonal antibodies (mAb) are still effective in fighting tumors that lack PD-L1 receptors on their cells.

Natural killer cells: Breakthrough study examines cancer-fighting behavior

July 24, 2019 | Letisia Marquez

For the first time, City of Hope scientists have discovered that natural killer cells provide one reason why anti-PD-L1 antibodies might work when tumor cells do not express PD-L1.

Combination Immunotherapy Shown to Be Effective Initial Treatment for Relapsed or Refractory Hodgkin Lymphoma

December 11, 2017 | Katie Neith

Researchers led by Alex Herrera, M.D. have found that a combination of two immunotherapy drugs may be a more tolerable way for patients to fight the disease before a transplant.